George N. Thalmann

George N. Thalmann publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where George N. Thalmann sits on this spectrum.

George N. Thalmann D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where George N. Thalmann sits on this spectrum.

Overview

Best Publications

• Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

  Nicholas D. James;Nicholas D. James;Matthew R. Sydes;Noel W. Clarke;Malcolm David Mason

  1568
  Citations

• European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

  J. Alfred Witjes;Harman Max Bruins;Richard Cathomas;Eva M. Compérat

  1429
  Citations

• Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.

  Christopher C Parker;Nicholas D James;Christopher D Brawley;Noel W Clarke

  1088
  Citations

• Radical Cystectomy for Bladder Cancer Today--A Homogeneous Series Without Neoadjuvant Therapy

  Stephan Madersbacher;Werner Hochreiter;Fiona Burkhard;George N. Thalmann

  972
  Citations

• Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

  Roland Seiler;Roland Seiler;Hussam Al Deen Ashab;Nicholas Erho;Bas W G van Rhijn

  771
  Citations

• An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer

  George van Andel;Andrew Bottomley;Sophie D. Fosså;Fabio Efficace

  492
  Citations

• Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

  Nicholas David James;Melissa R. Spears;Noel W. Clarke;David P. Dearnaley

  488
  Citations

• The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study.

  Agostino Mattei;Frank G. Fuechsel;Nivedita Bhatta Dhar;Sebastian H. Warncke

  458
  Citations

• LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.

  George N. Thalmann;Robert A. Sikes;Tony T. Wu;Armelle Degeorges

  454
  Citations

• High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer

  Christel van den Hoogen;Geertje van der Horst;Henry Cheung;Jeroen T. Buijs

  446
  Citations

• Twenty Years Experience With an Ileal Orthotopic Low Pressure Bladder Substitute—Lessons to be Learned

  Urs E. Studer;Fiona C. Burkhard;Martin Schumacher;Thomas M. Kessler

  444
  Citations

• Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

  Cora N Sternberg;Iwona Skoneczna;J Martijn Kerst;Peter Albers

  419
  Citations

• Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines

  Tony T. Wu;Robert A. Sikes;Quanjun Cui;George N. Thalmann

  409
  Citations

• Urinary diversion after radical cystectomy for bladder cancer: Options, patient selection, and outcomes

  Richard K. Lee;Hassan Abol-Enein;Walter Artibani;Bernard Bochner

  381
  Citations

• Outcome After Radical Cystectomy With Limited or Extended Pelvic Lymph Node Dissection

  Nivedita Bhatta Dhar;Eric A. Klein;Alwyn M. Reuther;George N. Thalmann

  372
  Citations

• Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer : a systematic review

  Guillaume Ploussard;Siamak Daneshmand;Jason A. Efstathiou;Harry W. Herr

  356
  Citations

• Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)

  Francesco Soria;Francesco Soria;Shahrokh F. Shariat;Seth P. Lerner;Hans Martin Fritsche

  354
  Citations

• PELVIC LYMPH NODE METASTASES FROM BLADDER CANCER: OUTCOME IN 83 PATIENTS AFTER RADICAL CYSTECTOMY AND PELVIC LYMPHADENECTOMY

  R.D. Mills;W.H. Turner;A. Fleischmann;R. Markwalder

  343
  Citations

• Osteopontin: Possible Role in Prostate Cancer Progression

  George N. Thalmann;R. A. Sikes;R. E. Devoll;J. A. Kiefer

  333
  Citations

• A Retrospective Analysis of 153 Patients Treated With or Without Intravesical Bacillus Calmette-Guerin for Primary Stage T1 Grade 3 Bladder Cancer: Recurrence, Progression and Survival

  Osama Shahin;George N. Thalmann;Cyrill Rentsch;L. Mazzucchelli

  312
  Citations